Form 4 for NKTR NEKTAR THERAPEUTICS

Accepted 2021-09-24 00:00:00 ET · period of report 2021-09-22 · accession 0001209191-21-057704 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-09-24	2021-09-22	NKTR	Curet Myriam	Dir	A - Grant	$0.00	+10.2K	29.4K	+53%	$0
D	2021-09-24	2021-09-22	NKTR	Curet Myriam	Dir	S - Sale	$17.78	-3,665	25.8K	-12%	-$65.2K
D	2021-09-24	2021-09-22	NKTR	Curet Myriam	Dir	A - Grant	$0.00	+20.4K	20.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-09-22	A	A	10,200	$0.00	29,440	D	—	—	(F1) Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.
2	Common	Common Stock	2021-09-22	S	D	3,665	$17.78	25,775	D	—	—	(F3) Represents the number of shares required to be sold by the reporting person to cover tax obligations in connection with the vesting of certain RSUs held by the reporting person. This sale is mandated by the reporting person's previous election under the Issuer's equity incentive plans to require the satisfaction of tax obligations to be funded by a "sell to cover" transaction.
3	Derivative	Stock Option	2021-09-22	A	A	20,400	$0.00	20,400	D	$17.78 · — to 2029-09-21	20,400 Common Stock	(F4) This stock option vests in equal monthly installments over the one-year period beginning on September 22, 2021.